<![CDATA[Bioventus LLC 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=22105>Wed, 22 Apr 2026 20:37:43 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide]]>https://www.newswire.co.kr/newsRead.php?no=911155Wed, 23 Sep 2020 15:00:00 +0900<![CDATA[바이오벤투스, ‘듀로레인’ 전 세계 치료 200만례 달성]]>https://www.newswire.co.kr/newsRead.php?no=911157Wed, 23 Sep 2020 15:00:00 +0900<![CDATA[바이오벤투스, ‘엑소젠’의 25년에 걸친 골절 치유 성과 입증]]>https://www.newswire.co.kr/newsRead.php?no=901703Tue, 25 Feb 2020 15:08:20 +0900<![CDATA[Bioventus Recognizes 25 Years of Proven Bone Healing from EXOGEN]]>https://www.newswire.co.kr/newsRead.php?no=901699Tue, 25 Feb 2020 14:37:21 +0900<![CDATA[영국 국립보건원, 초음파 골절 치유 시스템 ‘엑소젠’에 대한 기존 권고 유지]]>https://www.newswire.co.kr/newsRead.php?no=895368Thu, 10 Oct 2019 16:52:24 +0900<![CDATA[National Institute for Health and Clinical Excellence Maintains Previous Recommendation for EXOGEN® Ultrasound Bone Healing System]]>https://www.newswire.co.kr/newsRead.php?no=895367Thu, 10 Oct 2019 16:44:08 +0900<![CDATA[바이오벤투스, MTF바이오로직스와 함께 무릎 골관절염을 위한 차세대 태반 조직 제품 공동개발]]>https://www.newswire.co.kr/newsRead.php?no=889481Mon, 10 Jun 2019 12:00:55 +0900<![CDATA[Bioventus to Co-Develop Next Generation Placental Tissue Product for Knee Osteoarthritis with MTF Biologics]]>https://www.newswire.co.kr/newsRead.php?no=889480Mon, 10 Jun 2019 12:00:19 +0900<![CDATA[Bioventus Launches DUROLANE® in Malaysia and Selects Athrotech as Exclusive Distribution Partner]]>https://www.newswire.co.kr/newsRead.php?no=882941Thu, 31 Jan 2019 18:10:00 +0900<![CDATA[바이오벤투스, 말레이시아에서 듀로레인(DUROLANE®) 출시... 단독 배급업체로 아스로테크 선정]]>https://www.newswire.co.kr/newsRead.php?no=882942Thu, 31 Jan 2019 18:10:00 +0900<![CDATA[Bioventus Announces First Patients Enrolled in BONES Study for EXOGEN®]]>https://www.newswire.co.kr/newsRead.php?no=856433Mon, 18 Sep 2017 17:15:00 +0900<![CDATA[바이오벤투스, 엑소젠® 대상 본즈(BONES) 연구에 첫 환자가 등록했다고 발표]]>https://www.newswire.co.kr/newsRead.php?no=856434Mon, 18 Sep 2017 17:15:00 +0900<![CDATA[Bioventus to Invest in New Clinical Research for EXOGEN®]]>https://www.newswire.co.kr/newsRead.php?no=846776Thu, 16 Mar 2017 13:55:00 +0900<![CDATA[바이오벤투스, ‘엑소젠’(EXOGEN®)의 새 임상 연구 위해 투자]]>https://www.newswire.co.kr/newsRead.php?no=846777Thu, 16 Mar 2017 13:55:00 +0900<![CDATA[Bioventus Selects MEDSERVICE to Distribute DUROLANE® in Russia]]>https://www.newswire.co.kr/newsRead.php?no=843743Wed, 18 Jan 2017 11:25:00 +0900<![CDATA[바이오벤투스, 러시아에서 더롤레인 유통 업체로 메드서비스 선정]]>https://www.newswire.co.kr/newsRead.php?no=843744Wed, 18 Jan 2017 11:25:00 +0900<![CDATA[Bioventus Expands to Mexico with DUROLANE® for Knee Osteoarthritis Patients]]>https://www.newswire.co.kr/newsRead.php?no=839840Tue, 15 Nov 2016 17:45:00 +0900<![CDATA[바이오벤투스, 무릎 골관절염 환자 위해 멕시코에 DUROLANE® 출시]]>https://www.newswire.co.kr/newsRead.php?no=839841Tue, 15 Nov 2016 17:45:00 +0900<![CDATA[Bioventus Appoints Andrew McCartney Managing Director, International for EMEA]]>https://www.newswire.co.kr/newsRead.php?no=839371Wed, 09 Nov 2016 15:10:00 +0900<![CDATA[바이오벤투스, 앤드류 매카트니를 EMEA 지역 국제 부문 상무이사로 임명]]>https://www.newswire.co.kr/newsRead.php?no=839372Wed, 09 Nov 2016 15:10:00 +0900<![CDATA[Bioventus Launches DUROLANE® for Osteoarthritis Patients in Taiwan]]>https://www.newswire.co.kr/newsRead.php?no=814409Tue, 05 Jan 2016 16:50:00 +0900<![CDATA[바이오벤투스, 골관절염 치료 위해 대만에 DUROLANE® 출시]]>https://www.newswire.co.kr/newsRead.php?no=814410Tue, 05 Jan 2016 16:50:00 +0900<![CDATA[Bioventus Leaders Promoted to Manage International Business and Expansion]]>https://www.newswire.co.kr/newsRead.php?no=794608Thu, 11 Jun 2015 11:45:00 +0900<![CDATA[바이오벤투스, 경영진 승진 인사…해외 사업 및 글로벌 시장 공략 목적]]>https://www.newswire.co.kr/newsRead.php?no=794613Thu, 11 Jun 2015 11:45:00 +0900<![CDATA[Bioventus Releases New EXOGEN® and Performance Guarantee in Canada]]>https://www.newswire.co.kr/newsRead.php?no=745523Tue, 08 Apr 2014 12:00:00 +0900